Bessemer Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285M Buy
965,236
+87,065
+10% +$25.9M 0.45% 46
2025
Q4
$240M Sell
878,171
-35,688
-4% -$9.7M 0.37% 57
2025
Q3
$247M Sell
913,859
-2,598
-0.3% -$707K 0.38% 57
2025
Q2
$253M Buy
916,457
+5,049
+0.6% +$1.37M 0.41% 55
2025
Q1
$242M Sell
911,408
-11,397
-1% -$2.81M 0.43% 57
2024
Q4
$214M Buy
922,805
+901,425
+4,216% +$207M 0.35% 66
2024
Q3
$4.72M Buy
21,380
+376
+2% +$77.8K 0.01% 438
2024
Q2
$4.13M Sell
21,004
-361
-2% -$74.6K 0.01% 397
2024
Q1
$4.6M Buy
21,365
+17,230
+417% +$3.62M 0.01% 397
2023
Q4
$870K Sell
4,135
-697
-14% -$149K ﹤0.01% 688
2023
Q3
$967K Sell
4,832
-3,838
-44% -$763K ﹤0.01% 632
2023
Q2
$1.61M Buy
8,670
+1,298
+18% +$240K ﹤0.01% 530
2023
Q1
$1.41M Sell
7,372
-1,138
-13% -$206K ﹤0.01% 520
2022
Q4
$1.43M Sell
8,510
-2,914
-26% -$506K ﹤0.01% 509
2022
Q3
$2.02M Buy
11,424
+1,090
+11% +$215K 0.01% 444
2022
Q2
$2.12M Sell
10,334
-351
-3% -$74.4K 0.01% 429
2022
Q1
$2.54M Buy
10,685
+3,824
+56% +$898K 0.01% 310
2021
Q4
$1.57M Buy
6,861
+1,425
+26% +$314K ﹤0.01% 383
2021
Q3
$1.05M Sell
5,436
-1,485
-21% -$301K ﹤0.01% 404
2021
Q2
$1.47M Sell
6,921
-541
-7% -$114K ﹤0.01% 364
2021
Q1
$1.52M Sell
7,462
-1,824
-20% -$359K ﹤0.01% 354
2020
Q4
$1.69M Sell
9,286
-851
-8% -$145K ﹤0.01% 323
2020
Q3
$1.7M Sell
10,137
-725,679
-99% -$122M 0.01% 342
2020
Q2
$120M Buy
735,816
+24,482
+3% +$4.39M 0.38% 75
2020
Q1
$123M Sell
711,334
-6,007
-0.8% -$1.2M 0.5% 50
2019
Q4
$144M Buy
717,341
+1,630
+0.2% +$334K 0.47% 61
2019
Q3
$151M Sell
715,711
-63,068
-8% -$13.2M 0.54% 51
2019
Q2
$151M Sell
778,779
-194,699
-20% -$35.9M 0.51% 54
2019
Q1
$160M Sell
973,478
-305,061
-24% -$53.9M 0.62% 50
2018
Q4
$241M Buy
1,278,539
+1,272,109
+19,784% +$235M 1.05% 25
2018
Q3
$1.09M Buy
6,430
+810
+14% +$136K ﹤0.01% 550
2018
Q2
$921K Buy
5,620
+1,295
+30% +$212K ﹤0.01% 596
2018
Q1
$699K Sell
4,325
-5
-0.1% -$796 ﹤0.01% 673
2017
Q4
$632K Buy
4,330
+37
+0.9% +$5.27K ﹤0.01% 740
2017
Q3
$583K Sell
4,293
-8,267
-66% -$1.04M ﹤0.01% 805
2017
Q2
$1.57M Buy
12,560
+4,110
+49% +$492K 0.01% 534
2017
Q1
$1M Buy
8,450
+527
+7% +$63.4K ﹤0.01% 700
2016
Q4
$914K Buy
7,923
+7,633
+2,632% +$849K ﹤0.01% 733
2016
Q3
$30K Sell
290
-438
-60% -$45.7K ﹤0.01% 1290
2016
Q2
$71K Sell
728
-3,656
-83% -$346K ﹤0.01% 811
2016
Q1
$421K Sell
4,384
-2,979
-40% -$271K ﹤0.01% 584
2015
Q4
$668K Buy
7,363
+5,763
+360% +$542K ﹤0.01% 588
2015
Q3
$148K Sell
1,600
-186
-10% -$17.7K ﹤0.01% 788
2015
Q2
$166K Buy
1,786
+225
+14% +$21K ﹤0.01% 775
2015
Q1
$148K Sell
1,561
-785
-33% -$72.7K ﹤0.01% 771
2014
Q4
$209K Buy
2,346
+1,615
+221% +$137K ﹤0.01% 701
2014
Q3
$59K Buy
731
+331
+83% +$24.9K ﹤0.01% 857
2014
Q2
$28K Sell
400
-3,235
-89% -$228K ﹤0.01% 967
2014
Q1
$270K Buy
3,635
+2,544
+233% +$192K ﹤0.01% 622
2013
Q4
$86K Buy
1,091
+906
+490% +$70.9K ﹤0.01% 764
2013
Q3
$14K Hold
185
﹤0.01% 997
2013
Q2
$14K Buy
+185
New +$12.1K ﹤0.01% 985

Other funds holding CME

Bessemer Group's CME Position: Q1 2026 in Review

Bessemer Group increased its CME Group (CME) stake by 9.9% in Q1 2026, buying an estimated $25.9M and bringing the position to 965,236 shares worth $285M. The position accounts for 0.45% of the portfolio, ranked #46.

Bessemer Group first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Bessemer Group held 965,236 shares of CME Group worth $285M as of Q1 2026.
  • Bessemer Group bought 87,065 CME Group shares in Q1 2026, an estimated $25.9M.
  • CME Group made up 0.45% of Bessemer Group's portfolio in Q1 2026, its #46 holding.
  • Bessemer Group first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.